Lecture abstracts
W0
Cell-cell communication, development and disease: connections with connexins in the nervous system
W1
The natural history of primary progressive multiple sclerosis: a geographically based study
W2
Primary and secondary progressive multiple sclerosis: differences and similarities
W3
Members of the Caspr family demarcate different domains in myelinated axons
W4
Mechanisms underlying symptom production in MS
W5
Clinical pronostic indicators
W6
Role of axonal signals in central nervous system myelination
W7
The role of myelin in axonal regeneration
W8
Myelin and axonal damage in the active MS lesion: new perspectives with therapeutic implications
W9
Neuropathology and immunopathology of primary progressive multiple sclerosis
W10
Genetics of primary progressive MS
W11
Axonopathy and progressive loss of white matter in genetically mutant mice
W12
Axonal loss in human demyelinating diseases
W13
Biological markers and disease progression
W14
Magnetic resonance imaging as an early course predictor of multiple sclerosis
W15
Axonal loss: imaging with conventional MRI
W16
Axonal loss : imaging with new MRI techniques
W17
Monitoring disease progression in primary progressive multiple sclerosis
W18
Diagnostic criteria
W19
Early treatment of multiple sclerosis
W20
Treatment with Interferon Beta-1a (Avonex?) in patients at high-risk of developing multiple sclerosis: results of the CHAMPS study
W21
Immunomodulating treatment in PP?MS
W22
Neuroprotective treatment in primary progressive MS
W23
Mechanisms underlying the course of multiple sclerosis: which treatment and when?
W24
How to use mitoxantrone in active MS
W25
How to use mitoxantrone in secondary progressive multiple sclerosis
CONGRES ECTRIMS
6 - 9 septembre 2000
Toulouse
Retour au sommaire
Lectures
Orals
Posters
Recherche par nom d'auteur
